Nobiletin as an inducer of programmed cell death in cancer: a review
J Huang, Z Chang, Q Lu, X Chen, M Najafi - Apoptosis, 2022 - Springer
Cancer resistance to therapy is a big issue in cancer therapy. Tumours may develop some
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …
Nobiletin as an inducer of programmed cell death in cancer: a review
J Huang, C Zaoshang, L Quzhe… - … on Programmed Cell …, 2022 - search.proquest.com
Cancer resistance to therapy is a big issue in cancer therapy. Tumours may develop some
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …
Nobiletin as an inducer of programmed cell death in cancer: a review
J Huang, Z Chang, Q Lu, X Chen… - … on programmed cell …, 2022 - pubmed.ncbi.nlm.nih.gov
Cancer resistance to therapy is a big issue in cancer therapy. Tumours may develop some
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …
Nobiletin as an inducer of programmed cell death in cancer: a review.
J Huang, Z Chang, Q Lu, X Chen… - Apoptosis: an International …, 2022 - europepmc.org
Cancer resistance to therapy is a big issue in cancer therapy. Tumours may develop some
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …
mechanisms to reduce the induction of cell death, thus stimulating tumour growth. Cancer …